Evvy

Evvy sells at-home vaginal microbiome test kits and digital health reports; a single kit costs $129 and subscription re-tests run $99, placing the brand in the mid-range diagnostics tier. All orders are placed through evvy.com; the test is mailed to the customer, returned with a prepaid label, and results are delivered in a secure online dashboard. The company is the first direct-to-consumer test to use metagenomic sequencing to map the complete vaginal microbiome, including hard-to-culture bacteria and fungi. Results are paired with a personalized care plan written by certified clinicians and, when appropriate, prescription treatment offers that can be filled through Evvy’s partner pharmacy. Primary buyers are women experiencing recurrent infections, fertility challenges, or persistent irritation who want data-driven answers beyond standard OB-GYN swabs. The brand speaks to value-driven consumers who prioritize body literacy, open conversation about vaginal health, and science-backed, non-judgmental care. Evvy competes with general women’s probiotics, telehealth STI panels, and functional gynecology clinics. It differentiates by focusing solely on the vaginal microbiome, offering clinician-interpreted metagenomics at a lower price and faster turnaround than specialty labs, while avoiding the one-size-fits-all promises of supplement-only brands.